2. Signaling Pathways
  3. Stem Cell/Wnt
    TGF-beta/Smad
  4. TGF-beta/Smad
  5. TGF-beta/Smad Agonist

TGF-beta/Smad Agonist

TGF-beta/Smad Agonists (7):

Cat. No. Product Name Effect Purity
  • HY-100347
    SRI-011381
    		Agonist 99.58%
    SRI-011381 is an orally active TGF-β signaling agonist, exhibits neuroprotective effects.
  • HY-100347A
    SRI-011381 hydrochloride
    		Agonist 99.94%
    SRI-011381 hydrochloride is an orally active TGF-β signaling agonist, exhibits neuroprotective effects, with blood-brain barrier permeability.
  • HY-100534
    IDE 2
    		Agonist 99.00%
    IDE2 is a small molecule cell-permeable inducer of definitive endoderm formation in mouse and human embryonic stem cells (ESCs) by activating the TGF-βsignaling pathway.
  • HY-100347AR
    SRI-011381 hydrochloride (Standard)
    		Agonist
    SRI-011381 (hydrochloride) (Standard) is the analytical standard of SRI-011381 (hydrochloride) (HY-100347A). This product is intended for research and analytical applications. SRI-011381 hydrochloride is an orally active TGF-β signaling agonist, exhibits neuroprotective effects.
  • HY-179228
    AN02
    		Agonist
    AN02 is a derivative of Curcumin (HY-N0005). AN02 inhibits the proliferation and clonogenicity, migration and invasion of ovarian cancer cells. AN02 dose-dependently upregulates the expression of APC and mediates the degradation of CTLA-4 through SMAD4. In the small xenograft model, AN02 significantly inhibits tumor growth and reverses the tumor immune-suppressive microenvironment. AN02, when combined with Ipilimumab (HY-P9901), can enhance efficacy and inhibit epithelial-mesenchymal transition. AN02 can be used for the study of ovarian cancer.
  • HY-100347R
    SRI-011381 (Standard)
    		Agonist
    SRI-011381 (Standard) is the analytical standard of SRI-011381 (HY-100347). This product is intended for research and analytical applications. SRI-011381 is an orally active TGF-β signaling agonist, exhibits neuroprotective effects.
  • HY-100347S
    SRI-011381-d5
    		Agonist
    SRI-011381-d5 is the deuterium labeled SRI-011381 (HY-100347). SRI-011381 is an orally active TGF-β signaling agonist, exhibits neuroprotective effects.